The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer’s disease (AD). This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.